XWPharma

Company Deals

XWPharma Secures $205 M Valiloxybate Deal with Avadel

Fineline Cube Sep 8, 2025

China‑based XWPharma Ltd. announced today that it has entered into an exclusive licensing agreement with...

Company Drug

Novo Nordisk semaglutide Alzheimer’s biomarkers fail primary endpoint

Company Medical Device

Acotec V-otter Microcatheter Secures NMPA Approval for TACE Procedures

Company Deals

Youjia-Bio Tongee-Medical Nucleic-Acid-Drug Partnership Targets Diabetes

Company Drug

Fosun-Pharma FXS0887 ATR-Inhibitor Gets NMPA Phase 1 Nod